GENTAMICIN SULFATE (gentamicin sulfate/PF)
AMINOGLYCOSIDES, PARENTERAL·SEPSIS CAUSED BY ENTEROBACTER·+63
APP/NOVAPLUS
Indication
Pseudomonas aeruginosa biliary tract infection
A Pseudomonas aeruginosa biliary tract infection is a localized or ascending bacterial infection of the hepatobiliary system—most commonly presenting as acute cholangitis or cholecystitis—caused by the opportunistic Gram-negative pathogen *Pseudomonas aeruginosa*. Read more about Pseudomonas aeruginosa biliary tract infection
28 drugs 21 manufacturers
Drugs that treat it
Common Pseudomonas aeruginosa biliary tract infection therapies.
AMIKACIN SULFATE
STAPHYLOCOCCAL SEPTICEMIA·+60
HERITAGE PHARMA
AMIKACIN SULFATE
STAPHYLOCOCCAL SEPTICEMIA·+60
Teva Parenteral Medicines
AMIKACIN SULFATE
STAPHYLOCOCCAL SEPTICEMIA·+60
WEST-WARD,INC.
AMIKACIN SULFATE
STAPHYLOCOCCAL SEPTICEMIA·+60
APP PHARMACEUTI
AMIKACIN SULFATE
AMINOGLYCOSIDES, PARENTERAL·STAPHYLOCOCCAL SEPTICEMIA·+60
SAGENT PHARMACE
GENTAMICIN SULFATE
AMINOGLYCOSIDES, PARENTERAL·SEPSIS CAUSED BY ENTEROBACTER·+63
APP/FRESENIUS K
AMIKACIN SULFATE
STAPHYLOCOCCAL SEPTICEMIA·+60
APP/FRESENIUS K
GENTAMICIN SULFATE (gentamicin sulfate/PF)
AMINOGLYCOSIDES, PARENTERAL·SEPSIS CAUSED BY ENTEROBACTER·+63
FRESENIUS KABI
Filter & compare in the drug finder →Opens the drug finder with Pseudomonas aeruginosa biliary tract infection preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonA Pseudomonas aeruginosa biliary tract infection is a localized or ascending bacterial infection of the hepatobiliary system—most commonly presenting as acute cholangitis or cholecystitis—caused by the opportunistic Gram-negative pathogen *Pseudomonas aeruginosa*.
It predominantly affects hospitalized, immunocompromised, or surgically altered patients, particularly those with indwelling biliary stents, recent endoscopic retrograde cholangiopancreatography, or malignant and benign biliary duct obstructions.
Pathophysiologically, the organism colonizes and proliferates within static, obstructed bile, often producing biofilms that adhere to ductile epithelium or prosthetic hardware.
Clinically, it is characterized by fever, right upper quadrant abdominal pain, and jaundice, with an elevated risk of rapid progression to bacteremia, hepatic abscesses, and life-threatening septic shock due to the pathogen's virulence and frequent multidrug resistance.
- nih.gov
A Pseudomonas aeruginosa biliary tract infection is a localized or ascending bacterial infection of the hepatobiliary system—most commonly presenting as acute cholangitis or cholecystitis—caused by the opportunistic Gram-negative pathogen *Pseudomonas aeruginosa* It predominantly affects hospitalized, immunocompromised, or surgically altered patients, particularly those with indwelling biliary stents, recent endoscopic retrograde cholangiopancreatography, or malignant and benign biliary duct obs...
- litfl.com
A Pseudomonas aeruginosa biliary tract infection is a localized or ascending bacterial infection of the hepatobiliary system—most commonly presenting as acute cholangitis or cholecystitis—caused by the opportunistic Gram-negative pathogen *Pseudomonas aeruginosa* It predominantly affects hospitalized, immunocompromised, or surgically altered patients, particularly those with indwelling biliary stents, recent endoscopic retrograde cholangiopancreatography, or malignant and benign biliary duct obs...
- nih.gov
It predominantly affects hospitalized, immunocompromised, or surgically altered patients, particularly those with indwelling biliary stents, recent endoscopic retrograde cholangiopancreatography, or malignant and benign biliary duct obstructions
- nih.gov
Pathophysiologically, the organism colonizes and proliferates within static, obstructed bile, often producing biofilms that adhere to ductile epithelium or prosthetic hardware
- nih.gov
Clinically, it is characterized by fever, right upper quadrant abdominal pain, and jaundice, with an elevated risk of rapid progression to bacteremia, hepatic abscesses, and life-threatening septic shock due to the pathogen's virulence and frequent multidrug resistance
- luc.edu
Clinically, it is characterized by fever, right upper quadrant abdominal pain, and jaundice, with an elevated risk of rapid progression to bacteremia, hepatic abscesses, and life-threatening septic shock due to the pathogen's virulence and frequent multidrug resistance
Personalize your experience
Follow Pseudomonas aeruginosa biliary tract infection and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.